Ikonisys Completed a Capital Increase Through a Private Placement

Regulatory News:

Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories (the “Issuer”), today announces that it has completed a capital increase of €150k, by way of a private placement.

This transaction continues the path initiated by the company at the beginning of 2024 to enlarge its shareholder base via selected transactions, while strengthening its financial resources. The net proceeds of this issue, amounting to €150k, will support the company’s working capital needs and extend its financial visibility.

Legal terms of the Capital Increase

The implementation of this capital increase, carried out with cancellation of shareholders' subscription rights through a private placement, was approved by the Board of Directors of the Issuer at its meeting held on August 13, 2024 (the "Capital Increase").

The new shares will be issued on the basis of the 8^th resolution of the Issuer's shareholders' meeting held on June 28, 2023. The settlement-delivery of the new shares will take place on August 19, 2024.

The Capital Increase did not require the approval of a notice (“prospectus”) by the Autorité des marchés financiers (the “AMF”).

Main terms of the Capital Increase

The Issuer has issued a total of 100,000 new ordinary shares, with a par value of €0.5 each, to the investor, pursuant to article L. 411-2 1° of the French Monetary and Financial Code, in accordance with the 8^th resolution passed by its Annual General Meeting on June 28, 2023.

The issuance price of the new shares issued under the Capital Increase, equal to €1.5 per share, represents a premium of approximately 3% on the Ikonisys share price at the close of August 14, 2024.

Impact of the transaction in terms of liquidity risk management and financing horizon

As of December 31, 2023, and as mentioned in the financial report published on July 8, 2024, the Issuer's consolidated cash position amounted to €9.4k.

In order to strengthen its financial resources, Ikonisys completed a capital increase of €1m on December 28, 2023 and more recently two capital increases for a total cumulative sum of €400k on June and July 2024.

Taking into account these elements, the Capital Increase completed and the previously secured financing facility, the Company considers that it is now in a position to meet its financing needs for more than 12 months.